Clinical Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ahmad, N.
Right arrow Articles by Mukhtar, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ahmad, N.
Right arrow Articles by Mukhtar, H.
Clinical Cancer Research Vol. 7, 1466-1473, May 2001
© 2001 American Association for Cancer Research


Experimental Therapeutics, Preclinical Pharmacology

Resveratrol Causes WAF-1/p21-mediated G1-phase Arrest of Cell Cycle and Induction of Apoptosis in Human Epidermoid Carcinoma A431 Cells1

Nihal Ahmad2, Vaqar M. Adhami, Farrukh Afaq, Denise K. Feyes and Hasan Mukhtar

Department of Dermatology, Case Western Reserve University and University Hospitals of Cleveland, Cleveland, Ohio 44106

Resveratrol (trans-3,4',5,-trihydroxystilbene), a phytoalexin found in grapes, nuts, fruits, and red wine, is a potent antioxidant with cancer-preventive properties. The mechanism by which resveratrol imparts cancer chemopreventive effects is not clearly defined. Here, we demonstrate that resveratrol, via modulations in cyclin-dependent kinase (cdk) inhibitor-cyclin-cdk machinery, results in a G1-phase arrest of the cell cycle followed by apoptosis of human epidermoid carcinoma (A431) cells. Resveratrol treatment (1–50 µM for 24 h) of A431 cells resulted in a dose-dependent (a) inhibition of cell growth as shown by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, (b) G1-phase arrest of the cell cycle as shown by DNA cell cycle analysis, and (c) induction of apoptosis as assessed by ELISA. The immunoblot analysis revealed that resveratrol treatment causes a dose- and time-dependent (a) induction of WAF1/p21; (b) decrease in the protein expressions of cyclin D1, cyclin D2, and cyclin E; and (c) decrease in the protein expressions of cdk2, cdk4, and cdk6. Resveratrol treatment was also found to result in a dose- and time-dependent decrease in kinase activities associated with all of the cdks examined. Taken together, our study suggests that resveratrol treatment of the cells causes an induction of WAF1/p21 that inhibits cyclin D1/D2-cdk6, cyclin D1/D2-cdk4, and cyclin E-cdk2 complexes, thereby imposing an artificial checkpoint at the G1->S transition of the cell cycle. This series of events results in a G1-phase arrest of the cell cycle, which is an irreversible process that ultimately results in the apoptotic death of cancer cells. To our knowledge, this is the first systematic study showing the involvement of each component of cdk inhibitor-cyclin-cdk machinery during cell cycle arrest and apoptosis of cancer cells by resveratrol.




This article has been cited by other articles:


Home page
Cancer Res.Home page
L. Whyte, Y.-Y. Huang, K. Torres, and R. G. Mehta
Molecular Mechanisms of Resveratrol Action in Lung Cancer Cells Using Dual Protein and Microarray Analyses
Cancer Res., December 15, 2007; 67(24): 12007 - 12017.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
P. R. van Ginkel, D. Sareen, L. Subramanian, Q. Walker, S. R. Darjatmoko, M. J. Lindstrom, A. Kulkarni, D. M. Albert, and A. S. Polans
Resveratrol Inhibits Tumor Growth of Human Neuroblastoma and Mediates Apoptosis by Directly Targeting Mitochondria
Clin. Cancer Res., September 1, 2007; 13(17): 5162 - 5169.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
D. A. Benitez, E. Pozo-Guisado, A. Alvarez-Barrientos, P. M. Fernandez-Salguero, and E. A. Castellon
Mechanisms Involved in Resveratrol-Induced Apoptosis and Cell Cycle Arrest in Prostate Cancer-Derived Cell Lines
J Androl, March 1, 2007; 28(2): 282 - 293.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
D. Sareen, P. R. van Ginkel, J. C. Takach, A. Mohiuddin, S. R. Darjatmoko, D. M. Albert, and A. S. Polans
Mitochondria as the primary target of resveratrol-induced apoptosis in human retinoblastoma cells.
Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3708 - 3716.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Ulrich, S. M. Loitsch, O. Rau, A. von Knethen, B. Brune, M. Schubert-Zsilavecz, and J. M. Stein
Peroxisome Proliferator-Activated Receptor {gamma} as a Molecular Target of Resveratrol-Induced Modulation of Polyamine Metabolism.
Cancer Res., July 15, 2006; 66(14): 7348 - 7354.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
H. Jiang, L. Zhang, J. Kuo, K. Kuo, S. C. Gautam, L. Groc, A. I. Rodriguez, D. Koubi, T. Jackson Hunter, G. B. Corcoran, et al.
Resveratrol-induced apoptotic death in human U251 glioma cells
Mol. Cancer Ther., April 1, 2005; 4(4): 554 - 561.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. C. Lazze, M. Savio, R. Pizzala, O. Cazzalini, P. Perucca, A. I. Scovassi, L. A. Stivala, and L. Bianchi
Anthocyanins induce cell cycle perturbations and apoptosis in different human cell lines
Carcinogenesis, August 1, 2004; 25(8): 1427 - 1433.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. A. Ahmad, M.-V. Clement, I. M. Hanif, and S. Pervaiz
Resveratrol Inhibits Drug-Induced Apoptosis in Human Leukemia Cells by Creating an Intracellular Milieu Nonpermissive for Death Execution
Cancer Res., February 15, 2004; 64(4): 1452 - 1459.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. W. Opipari Jr., L. Tan, A. E. Boitano, D. R. Sorenson, A. Aurora, and J. R. Liu
Resveratrol-induced Autophagocytosis in Ovarian Cancer Cells
Cancer Res., January 15, 2004; 64(2): 696 - 703.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
A. R. Jazirehi and B. Bonavida
Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis
Mol. Cancer Ther., January 1, 2004; 3(1): 71 - 84.
[Abstract] [Full Text]


Home page
FASEB J.Home page
S. PERVAIZ
Resveratrol: from grapevines to mammalian biology
FASEB J, November 1, 2003; 17(14): 1975 - 1985.
[Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. J. Gescher and W. P. Steward
Relationship between Mechanisms, Bioavailibility, and Preclinical Chemopreventive Efficacy of Resveratrol: A Conundrum
Cancer Epidemiol. Biomarkers Prev., October 1, 2003; 12(10): 953 - 957.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. Favot, S. Martin, T. Keravis, R. Andriantsitohaina, and C. Lugnier
Involvement of cyclin-dependent pathway in the inhibitory effect of delphinidin on angiogenesis
Cardiovasc Res, August 1, 2003; 59(2): 479 - 487.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. R. Stewart, M. C. Artime, and C. A. O'Brian
Resveratrol: A Candidate Nutritional Substance for Prostate Cancer Prevention
J. Nutr., July 1, 2003; 133(7): 2440S - 2443.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
S. Kuruvilla, C. W. Qualls Jr., R. D. Tyler, S. M. Witherspoon, G. R. Benavides, L. W. Yoon, K. Dold, R. H. Brown, S. Sangiah, and K. T. Morgan
Effects of Minimally Toxic Levels of Carbonyl Cyanide P-(Trifluoromethoxy) Phenylhydrazone (FCCP), Elucidated through Differential Gene Expression with Biochemical and Morphological Correlations
Toxicol. Sci., June 1, 2003; 73(2): 348 - 361.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
U. G. B. Haider, D. Sorescu, K. K. Griendling, A. M. Vollmar, and V. M. Dirsch
Resveratrol Increases Serine15-Phosphorylated but Transcriptionally Impaired p53 and Induces a Reversible DNA Replication Block in Serum-Activated Vascular Smooth Muscle Cells
Mol. Pharmacol., April 1, 2003; 63(4): 925 - 932.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
F. Wolter and J. Stein
Resveratrol Enhances the Differentiation Induced by Butyrate in Caco-2 Colon Cancer Cells
J. Nutr., July 1, 2002; 132(7): 2082 - 2086.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
A. L. Gartel and A. L. Tyner
The Role of the Cyclin-dependent Kinase Inhibitor p21 in Apoptosis
Mol. Cancer Ther., June 1, 2002; 1(8): 639 - 649.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G.-Z. Tao, L. S. Rott, A. W. Lowe, and M. B. Omary
Hyposmotic Stress Induces Cell Growth Arrest via Proteasome Activation and Cyclin/Cyclin-dependent Kinase Degradation
J. Biol. Chem., May 24, 2002; 277(22): 19295 - 19303.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Agrawal, M. L. Agarwal, M. Chatterjee-Kishore, G. R. Stark, and G. M. Chisolm
Stat1-Dependent, p53-Independent Expression of p21waf1 Modulates Oxysterol-Induced Apoptosis
Mol. Cell. Biol., April 1, 2002; 22(7): 1981 - 1992.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. K. Joe, H. Liu, M. Suzui, M. E. Vural, D. Xiao, and I. B. Weinstein
Resveratrol Induces Growth Inhibition, S-phase Arrest, Apoptosis, and Changes in Biomarker Expression in Several Human Cancer Cell Lines
Clin. Cancer Res., March 1, 2002; 8(3): 893 - 903.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.